Сегодня 07 октября 2022
Медикус в соцсетях
 
Задать вопрос

ЗАДАТЬ ВОПРОС РЕДАКТОРУ РАЗДЕЛА (ответ в течение нескольких дней)

Представьтесь:
E-mail:
Не публикуется
служит для обратной связи
Антиспам - не удалять!
Ваш вопрос:
Получать ответы и новости раздела
17 мая 2002 00:00   |   Miha Sok, MD, PhD*a, Marjeta entjurc, PhDb, Milan Schara, PhDb, Janez Stare, PhDc, Toma Rott, MD, PhDd

Cell membrane fluidity and prognosis of lung cancer

Background. Membranes of tumor cells have been found to posses higher fluidity than membranes of nontumor cells. Plasma membrane fluidity is significantly correlated with malignant potential of these cells.
Methods. Seventy-five patients operated on for lung cancer were studied prospectively. During the operation, lung tumor samples were taken from the resected lung for evaluation by electron paramagnetic resonance. The fluidity variable H13, which is proportional to the plasma membrane fluidity, was determined from the electron paramagnetic resonance spectra. The association between H13 and survival was determined by survival analysis using Kaplan-Meier curves and Cox regression.
Results. Pathologic TNM stage and the fluidity variable H13 were the only prognostic variables significantly associated with survival time in multivariate proportional hazards regression model. Thus, H13 was shown to be an independent prognostic variable for survival, which was also confirmed by a separate analysis relating the TNM stage and H13. Dividing the patients into two groups, one with an H13 value higher than the median and another with H13 below the median, resulted in significantly different survival curves (p = 0.01).
Conclusions. Patients with high plasma membrane fluidity, indicated by high H13 of the resected lung tumor tissue, seem to have poorer prognosis than those with less fluid membranes. We suggest that the fluidity variable could be used as an independent additional prognostic factor and a tool to identify patients who may be helped by adjuvant postoperative therapy.

Поделиться:




Комментарии
Смотри также
17 мая 2002  |  00:05
Usefulness of videothoracoscopic intrapericardial examination of pulmonary vessels to identify resectable clinical T4 lung cancer
Background. Discrepancies in predicting resectability by imaging techniques (computed tomography and magnetic resonance imaging) compared with actual intraoperative findings have persuaded us
17 мая 2002  |  00:05
Pulmonary blastoma: medium-term results from a regional center
Background. Pulmonary blastomas are rare lung tumors that morphologically resemble fetal pulmonary structure and can exist in two forms, biphasic and monophasic. We reviewed our experience over
17 мая 2002  |  00:05
Neural networks as a prognostic tool of surgical risk in lung resections
Background. Assessment of surgical risk in patients undergoing pulmonary resection is a fundamental goal for thoracic surgeons. Usually used risk indices do not predict the individual outcome.
17 мая 2002  |  00:05
Natriuretic peptides after pulmonary resection
Background. Little is known about alterations in the levels and influence of natriuretic peptide (NP) on cardiopulmonary function after pulmonary resection for lung cancer. This study was designed
17 мая 2002  |  00:05
Outcomes of lung volume reduction surgery followed by lung transplantation: a matched cohort study
Background. Lung volume reduction surgery (LVRS) has been demonstrated to provide symptomatic relief and to improve lung function in patients with end-stage emphysema. The goal of this study was